retatrutide regulatory approval A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity Retatrutide Delivers Significant Hemoglobin A1C
Pay in 4 interest-free payments of $6.39 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

























